Computational Approaches to Drug Design

被引:0
|
作者
P. W. Finn
L. E. Kavraki
机构
[1] Pfizer Central Research,
[2] Sandwich,undefined
[3] Kent,undefined
[4] England. Author's current address: Prolofix Ltd.,undefined
[5] 91 Milton Park,undefined
[6] Milton,undefined
[7] Oxfordshire,undefined
[8] England.,undefined
[9] Department of Computer Science,undefined
[10] Rice University,undefined
[11] Houston,undefined
[12] TX 77005,undefined
[13] USA. kavraki@cs.rice.edu.,undefined
来源
Algorithmica | 1999年 / 25卷
关键词
Key words. Computer-assisted pharmaceutical drug design, Molecular surfaces, Conformational search, Pharmacophore identification.;
D O I
暂无
中图分类号
学科分类号
摘要
The rational approach to pharmaceutical drug design begins with an investigation of the relationship between chemical structure and biological activity. Information gained from this analysis is used to aid the design of new, or improved, drugs. Primary considerations during this investigation are the geometric and chemical characteristics of the molecules. Computational chemists who are involved in rational drug design routinely use an array of programs to compute, among other things, molecular surfaces and molecular volume, models of receptor sites, dockings of ligands inside protein cavities, and geometric invariants among different molecules that exhibit similar activity. There is a pressing need for efficient and accurate solutions to the above problems. {Often, limiting assumptions need to be made, in order to make the calculations tractable. Also,} the amount of data processed when searching for a potential drug is currently very large and is only expected to grow larger in the future. This paper describes some areas of computer-aided drug design that are important to computational chemists but are also rich in algorithmic problems. It surveys recent work in these areas both from the computational chemistry and the computer science literature.
引用
收藏
页码:347 / 371
页数:24
相关论文
共 50 条
  • [1] Computational approaches to drug design
    Finn, PW
    Kavraki, LE
    ALGORITHMICA, 1999, 25 (2-3) : 347 - 371
  • [2] Computational Approaches for Drug Design: A Focus on Drug Repurposing
    Kim, Suyeon
    Thapa, Ishwor
    Samadi, Farial
    Ali, Hesham
    BIOINFORMATICS AND BIOMEDICAL ENGINEERING (IWBBIO 2020), 2020, 12108 : 213 - 223
  • [3] Computational approaches to anti-cancer drug design
    Taylor, SA
    Feldgus, S
    Shields, GC
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U505 - U506
  • [4] Integrated Computational Approaches for Drug Design Targeting Cruzipain
    Parvez, Aiman
    Lee, Jeong-Sang
    Alam, Waleed
    Tayara, Hilal
    Chong, Kil To
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)
  • [5] Computational approaches to model ligand selectivity in drug design
    Ortiz, AR
    Gomez-Puertas, P
    Leo-Macias, A
    Lopez-Romero, P
    Lopez-Viñas, E
    Morreale, A
    Murcia, M
    Wang, K
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (01) : 41 - 55
  • [6] Improving the rationale for drug design by developing computational approaches
    Bai, Fang
    Nechushtai, Rachel
    Li, Honglin
    Jiang, Hualiang
    Onuchic, Jose
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [7] STRUCTURE-AIDED DRUG DESIGN - CRYSTALLOGRAPHY AND COMPUTATIONAL APPROACHES
    RINGE, D
    JOURNAL OF NUCLEAR MEDICINE, 1995, 36 (06) : S28 - S30
  • [8] Computational Approaches: Drug Discovery and Design in Medicinal Chemistry and Bioinformatics
    Tutone, Marco
    Almerico, Anna Maria
    MOLECULES, 2021, 26 (24):
  • [9] A review of the current trends in computational approaches in drug design and metabolism
    Russell B. O. Ouma
    Silas M. Ngari
    Joshua K. Kibet
    Discover Public Health, 21 (1)
  • [10] Fragment Based Drug Design: From Experimental to Computational Approaches
    Kumar, A.
    Voet, A.
    Zhang, K. Y. J.
    CURRENT MEDICINAL CHEMISTRY, 2012, 19 (30) : 5128 - 5147